Location History:
- Basel, CH (2015 - 2018)
- Munich, DE (2022)
Company Filing History:
4 out of 3,923 
2 out of 1,975 
Years Active: 2015-2022
Title: The Innovative Contributions of Malte Peters
Introduction
Malte Peters is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of four patents to his name, Peters has focused on developing combination therapies that enhance the effectiveness of cancer treatments.
Latest Patents
Among his latest patents, Peters has disclosed a combination comprising an immunomodulator and a second therapeutic agent for use in treating cancer. The immunomodulator can be an inhibitor of an immune checkpoint molecule or an activator of a costimulatory molecule, or a combination thereof. The second therapeutic agent is selected from various inhibitors, including c-MET, CDK4/6, PI3K, BRAF, FGFR, MEK, or BCR-ABL inhibitors. These combination therapies are designed to treat or prevent cancerous conditions and disorders. Additionally, he has developed combination therapies involving EGFR inhibitors, which also aim to treat or prevent cancerous conditions.
Career Highlights
Throughout his career, Malte Peters has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Amgen Inc. His work has been instrumental in advancing cancer treatment options and improving patient outcomes.
Collaborations
Peters has collaborated with esteemed colleagues such as David E. Lebwohl and Xizhong Huang, contributing to the development of innovative therapeutic strategies.
Conclusion
Malte Peters is a distinguished inventor whose work in combination therapies has the potential to revolutionize cancer treatment. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient care.